{
  "id": 2120804,
  "title": "Think Investments, ValueQuest And Others Invest ₹648 Crore In Symbiotec Pharmalab Ahead Of IPO",
  "url": "https://urgent.news/2026/08/20/think-investments-valuequest-and-others-invest-648-crore-in-symbiotec",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-20T11:07:57.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/think-investments-valuequest-and-others-invest-648-crore-in-symbiotec-pharmalab-ahead-of-ipo"
  },
  "original_language": "en",
  "account": "New Delhi: Symbiotec Pharmalab has managed to secure a significant investment of ₹648 crore from various investors in anticipation of its upcoming ₹1,757-crore IPO. Think India Opportunities Master Fund, Dymon Asia Multi-Strategy Investment, ValueQuest, WhiteOak Capital, Singularity Equity Fund I, Waterfield Flagship Fund I, Landmark Capital Markets, and Rosewood Investments are among the prominent investors who have taken a 10.4 per cent stake in the company. The shares were exchanged for a price of Rs 988 each on August 19, making the transaction value ₹647.89 crore. The company plans to issue a fresh share offering worth up to Rs 150 crore and an Offer-for-Sale (OFS) of shares worth up to Rs 1,607 crore. The IPO is set to commence on August 24 and conclude on August 27, with anchor investors bidding on August 21. The price band for the IPO ranges from Rs 938-988 per share, valuing the company at approximately Rs 6,350 crore at the upper end.",
  "summary": "New Delhi: Think India Opportunities Master Fund, Dymon Asia Multi-Strategy Investment, ValueQuest and WhiteOak Capital are among investors that have picked up a 10.4 per cent stake in Symbiotec Pharmalab for nearly Rs 648 crore through a secondary share transaction, ahead of its Rs 1,757-crore IPO. A total of 65.57 lakh equity shares, amounting to 10.4 per cent stake, changed hands on August 19…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}